Incidence and outcomes of systemic infections in patients with leadless pacemakers: Data from the Micra IDE study
68 Citations•2019•
Michael El-Chami, K. Soejima, J. Piccini
Pacing and Clinical Electrophysiology
The Micra clinical trials have enrolled more than 2500 patients without any reported device‐related infections that required removal during follow-up, and leadless pacemakers might be more resistant to bacterial seeding due to smaller surface area and a greater tendency for encapsulation.
Abstract
The Micra clinical trials have enrolled more than 2500 patients without any reported device‐related infections that required removal during follow‐up. Leadless pacemakers might be more resistant to bacterial seeding due to smaller surface area and a greater tendency for encapsulation.